These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8492074)

  • 21. LHRH agonist and contraception.
    Hoffmann G; Schommer M; Pollow K; von der Ohe M
    Prog Clin Biol Res; 1986; 225():325-35. PubMed ID: 3097671
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.
    Kiilholma P; Tuimala R; Kivinen S; Korhonen M; Hagman E
    Fertil Steril; 1995 Nov; 64(5):903-8. PubMed ID: 7589632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse.
    Bain SD; Jensen E; Celino DL; Bailey MC; Lantry MM; Edwards MW
    J Bone Miner Res; 1993 Feb; 8(2):219-30. PubMed ID: 8442440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
    Notelovitz M; Cassel D; Hille D; Furst KW; Dain MP; VandePol C; Skarinsky D
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):7-12. PubMed ID: 10649149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progestogen therapy during pituitary desensitization with gonadotropin-releasing hormone agonist prevents functional ovarian cyst formation: a prospective, randomized study.
    Engmann L; Maconochie N; Bekir J; Tan SL
    Am J Obstet Gynecol; 1999 Sep; 181(3):576-82. PubMed ID: 10486466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of administration and subsequent cessation of buserelin on cancellous bone of female rats.
    Tobias JH; Chambers TJ; Gallagher A
    J Bone Miner Res; 1994 Dec; 9(12):1919-25. PubMed ID: 7872057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid inhibitory effects of an LHRH agonist implant on the oestrogen-induced LH surge and the induction of a defective luteal phase after an agonist-induced ovulation in the macaque.
    Fraser HM; Lunn SF
    Hum Reprod; 1989 Jul; 4(5):506-12. PubMed ID: 2507574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing an Animal Model of Secondary Osteoporosis by Using a Gonadotropin-releasing Hormone Agonist.
    Mohamad NV; Che Zulkepli MAA; May Theseira K; Zulkifli N; Shahrom NQ; Ridzuan NAM; Jamil NA; Soelaiman IN; Chin KY
    Int J Med Sci; 2018; 15(4):300-308. PubMed ID: 29511366
    [No Abstract]   [Full Text] [Related]  

  • 31. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.
    Albano C; Felberbaum RE; Smitz J; Riethmüller-Winzen H; Engel J; Diedrich K; Devroey P
    Hum Reprod; 2000 Mar; 15(3):526-31. PubMed ID: 10686191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of LHRH agonist (buserelin) on pulsatile secretion of LHRH and LH.
    Okuda K; Ushiroyama T; Yoshikawa M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1889-93. PubMed ID: 3145318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of three hormone replacement regimens on bone density in the aged ovariectomized rat.
    Vanin CM; MacLusky NJ; Grynpas MD; Casper RF
    Fertil Steril; 1995 Mar; 63(3):643-51. PubMed ID: 7851600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis.
    Surrey ES; Gambone JC; Lu JK; Judd HL
    Fertil Steril; 1990 Apr; 53(4):620-6. PubMed ID: 2108056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
    Hirvonen E; Mälkönen M; Manninen V
    N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of planned in-vitro fertilization programming through the pre-administration of the oestrogen-progesterone combined pill.
    Cohen J; Debache C; Solal P; Serkine AM; Achard B; Boujenah A; Pez JP; Paris X; Robert J; Loffredo V
    Hum Reprod; 1987 Jan; 2(1):7-9. PubMed ID: 3106405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review.
    Riis BJ; Lehmann HJ; Christiansen C
    Am J Obstet Gynecol; 2002 Oct; 187(4):1101-16. PubMed ID: 12389012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.
    Brogden RN; Buckley MM; Ward A
    Drugs; 1990 Mar; 39(3):399-437. PubMed ID: 2109679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventive effects of a herbal medicine on bone loss in rats treated with a GnRH agonist.
    Sakamoto S; Sassa S; Kudo H; Suzuki S; Mitamura T; Shinoda H
    Eur J Endocrinol; 2000 Jul; 143(1):139-42. PubMed ID: 10870043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.